In the wake of the Farm Bill, there are a few companies that should be able to capitalize in a big way on that story if the market feels they have a real case to be made, with Medical Marijuana Inc (OTCMKTS:MJNA) being a primary case in point. However, as should be plain on the chart, the stock has been fading fast in the wake of that announcement, which brings into play plenty of questions for long-time investors because, as should be quite clear, if you’re in this stock and waiting for that proverbial big catalyst, you just got it. And shares aren’t animating.
To help further flesh that story out, the company just announced the launch of its latest cannabidiol (CBD) pet product, Phyto Animal Health Vitality 3G Oral Concentrate. “We worked closely with our Veterinary Advisory Board and CBD experts to formulate this newest addition to our product line and we couldn’t be more excited for it to launch,” said Phyto Animal Health CEO Ian Quinn. “This new supplement will be targeted to veterinary clinicians and animal hospitals and we hope that it will help them learn about the many potential benefits of CBD.”
Medical Marijuana Inc (OTCMKTS:MJNA) casts itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.
MJNA’s subsidiary, Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products
MJNA licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.
In addition, MJNA provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products, sportswear and more.”
According to company materials, “Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.”
Find out when $MJNA reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, MJNA just announced the launch of its latest cannabidiol (CBD) pet product, Phyto Animal Health Vitality 3G Oral Concentrate. In all, we’ve witnessed 18% tacked on to share pricing for the stock in the past month.
Moreover, the stock has seen a growing influx of trading interest, with the stock’s recent average trading volume running 87% above the average volume levels in play in this stock over the longer term.
“It’s encouraging to see the tremendous growth and acceptance the veterinary field has made in cannabis over the past few years,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope to continue to innovate our product offerings for both humans and other species as new research becomes available.”
Currently trading at a market capitalization of $279.91M, MJNA has a significant war chest ($4.8M) of cash on the books, which stands against about $4M in total current liabilities. One should also note that debt has been growing over recent quarters. MJNA is pulling in trailing 12-month revenues of $51.6M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 116.2%. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $MJNA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $MJNA, either long or short, and we have not been compensated for this article.